Topotecan Pharmacokinetic Characterization Study
NCT00361803
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
topotecan
Sponsor
GlaxoSmithKline